Markets
4 views
Natco Pharma Q1 profit falls 57 pc to Rs 206.5 cr
Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated.
Economictimes Verified Source
Syndicated via official news feed
Explore all Markets stories
Syndicated feed content with full publisher credit.
Markets Desk
More in Markets
Continue reading verified coverage and related developments on this desk.
More from Markets
Latest developments and reports from the desk
MARKETS
Indonesia’s lessons for the global energy transition
Country’s solar push highlights momentum — and obstacles — around green energy shift
MARKETS
Gaja Alternative share price slumps over 8% after strong debut. Should you buy, sell or hold?
Gaja Alternative's share price dropped more than 8% after a strong debut at a premium of around 16%. Despite this correction, it remained over 6% above its IPO price. Analysts suggest a cautious approach to investment…
MARKETS
Wall Street’s Best Oil Stock of 2026 Isn’t Who You Think
Wall Street’s Best Oil Stock of 2026 Isn’t Who You Think